When the four adjuvant modalities were considered in combination, a lower hazard of recurrence was observed (HR = 0.75, 95% CI 0.41–1.38); however, this association did not reach statistical significance ( Figure 5 g). 4.
← all excerpts
Clinical and Therapeutic Predictors of Keloid Recurrence: Outcomes in a European Cohort of 206 Patients.
1
—
—